DBVT FY 2023 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16M+227.7% YoY

Gross Profit

$16M100.0% margin

Operating Income

-$76M-486.0% margin

Net Income

-$73M-462.4% margin

EPS (Diluted)

$-3.80

Cash Flow

Operating Cash Flow

-$80M

Free Cash Flow

-$80M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$183M

Total Liabilities

$43M

Stockholders' Equity

$140M

Cash & Equivalents

$141M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$5M	+227.7%
Gross Profit	$16M	-$15M	+201.5%
Operating Income	-$76M	-$97M	+20.9%
Net Income	-$73M	-$96M	+24.5%